Anti-HER2-targeted therapies: effects on human in vitro blood-brain barrier models
{{output}}
Metastatic breast cancer is associated with very poor overall survival and a reduced quality of life. HER2-positive breast cancer forms brain metastases at the late stages. Established therapies such as trastuzumab, pertuzumab, trastuzumab/pertuzumab, lapatini... ...
